Systemic Sclerosis-associated Interstitial Lung Disease
📧 Sign up to get email alerts when something new happens for Systemic Sclerosis-associated Interstitial Lung Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2024-08-27Clinical Trial Update: Efficacy and Safety of JAK Inhibitors in Systemic Sclerosis-associated Interstitial Lung Disease
A clinical trial evaluating JAK inhibitors for systemic sclerosis–associated interstitial lung disease has been withdrawn.